SCHEMBL16500484

SCHEMBL16500484

COC(C)/C(=C\c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
AKR1C1 Q04828 1/20 0.40
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
AKR1C3 P42330 1/20 0.37
PRMT1 Q99873 1/20 0.37
HPGD P15428 2/20 0.36
ESR1 P03372 1/20 0.36
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36
CYP19A1 P11511 1/20 0.35
CYP11B2 P19099 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297682 0.84 AKR1C1 (0.39) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL2835097 0.80 AKR1C1 (0.45) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL5960470 0.80 AKR1C1 (0.45) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL8528509 0.74 AKR1C1 (0.47) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL27835257 0.72 AKR1C1 (0.50) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL27806267 0.72 AKR1C1 (0.45) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL146717 0.72 AKR1C1 (0.45) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL10711205 0.72 AKR1C1 (0.45) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL4375040 0.71 L3MBTL1 (0.47) MEN1KMT2AAKR1C1ALDH1A1TSHR
SCHEMBL7892823 0.70 ALDH1A1 (0.46) MEN1KMT2AAKR1C1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110295019-A1 Method for Producing Hydroxymethyl Diphenyloxiranes and Corresponding 1-azolylmethyl-1,2-diphenyloxiranes BASF SE (DE) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295019-A1 Method for Producing Hydroxymethyl Diphenyloxiranes and Corresponding 1-azolylmethyl-1,2-diphenyloxiranes DHPS, HMOX2, HMOX1 MEN1 3376/4885KMT2A 572/4885AKR1C1 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.